Blepharospasm with non-satisfactory response to treatment: our experience with IncobotulinumtoxinA

Parkinsonism Relat Disord. 2014 Jun;20(6):665-7. doi: 10.1016/j.parkreldis.2013.12.013. Epub 2014 Jan 8.

Authors

Lucia Ricciardi¹, Tamara Ialongo², Arianna Guidubaldi², Raffaella Di Giacopo², Anna Rita Bentivoglio³

Affiliations

¹ Department of Neurology, Università Cattolica del Sacro Cuore, Rome, Italy; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
² Department of Neurology, Università Cattolica del Sacro Cuore, Rome, Italy.
³ Department of Neurology, Università Cattolica del Sacro Cuore, Rome, Italy. Electronic address: annarita.bentivoglio@rm.unicatt.it.

PMID: 24685658
DOI: 10.1016/j.parkreldis.2013.12.013

No abstract available

Keywords: Blepharospasm; Botulinum toxin; IncobotulinumtoxinA; Secondary non responders.

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Blepharospasm / drug therapy*
Botulinum Toxins, Type A / therapeutic use*
Cross-Sectional Studies
Disability Evaluation
Female
Humans
Male
Neuromuscular Agents / therapeutic use*
Retrospective Studies
Treatment Failure
Treatment Outcome
Visual Analog Scale

Substances

Neuromuscular Agents
Botulinum Toxins, Type A
incobotulinumtoxinA